Crocus sativus updated

Zusammenfassung

Die goldgelben Stigmen des Safrans werden seit der Antike nicht nur für Kultzwecke und zum Färben, sondern auch als Heilmittel genutzt. Der Beitrag stellt relevante Forschungsergebnisse der letzten Jahre bei verschiedenen Indikationen vor.

Abstract

The golden-yellow stigmas of saffron have been used since ancient times not only for cult purposes and dyeing, but also as a remedy. The article presents relevant research results from recent years for various indications.

Publication History

Article published online:
26 February 2024

• Literatur

• 1 Ahmadpanah M, Ramezanshams F, Ghaleiha A. et al. Crocus sativus L. (saffron) versus sertraline on symptoms of depression among older people with major depressive disorders – a double-blind, randomized intervention study. Psychiatry Res 2019; 282: 112613
• 2 Ayati Z, Yang G, Ayati MH. et al. Saffron for mild cognitive impairment and dementia: a systematic review and meta-analysis of randomised clinical trials. BMC Complement Med Ther 2020; 20: 333
• 3 Bian Y, Zhao C, Lee SM. Neuroprotective potency of saffron against neuropsychiatric diseases, neurodegenerative diseases, and other brain disorders: From bench to bedside. Front Pharmacol 2020; 11: 579052
• 4 Blaschek W, Hilgenfeldt U, Holzgrebe U, Mörike K, Reichling J, Ruth P. Hrsg. HagerROM – Hagers Enzyklopädie der Arzneistoffe und Drogen. Stuttgart: Wiss. Verl.-Ges; 2016
• 5 Boozari M, Hosseinzadeh H. Crocin molecular signaling pathways at a glance: A comprehensive review. Phytother Res 2022; 36: 3859-3884
• 6 Bozorgi H, Ghahremanfard F, Motaghi E. et al. Effectiveness of crocin of saffron (Crocus sativus L.) against chemotherapy-induced peripheral neuropathy: A randomized, double-blind, placebo-controlled clinical trial. J Ethnopharmacol 2021; 281: 114511
• 7 Butnariu M, Quispe C, Herrera-Bravo J. et al. The pharmacological activities of Crocus sativus L.: A review based on the mechanisms and therapeutic opportunities of its phytoconstituents. Oxid Med Cell Longev 2022; 2022: 8214821
• 8 Cerdá-Bernad D, Costa L, Serra AT. et al. Saffron against neuro-cognitive disorders: An overview of its main bioactive compounds, their metabolic fate and potential mechanisms of neurological protection. Nutrients 2022; 14: 5368
• 9 Chrubasik-Hausmann S. Safran – das pflanzliche Gold ist vielseitig nutzbar. zkm – Z Komplementärmed 2020; 6: 50-53 DOI: 10.1055/a-1295-6716.
• 10 Chrubasik-Hausmann S. Wirksamkeit von Safran beim Aufmerksamkeitsdefizit-/Hyperaktivitätssyndrom (ADHS). Z Phythother 2023; 44: 15-20 DOI: 10.1055/a-1924-9538.
• 11 Correia AGDS, Alencar MB, Dos Santos AN. et al. Effect of saffron and fenugreek on lowering blood glucose: A systematic review with meta-analysis. Phytother Res 2023; 37: 2092-2101
• 12 El Midaoui A, Ghzaiel I, Vervandier-Fasseur D. et al. Saffron (Crocus sativus L.): A source of nutrients for health and for the treatment of neuropsychiatric and age-related diseases. Nutrients 2022; 14: 597
• 13 Giannoulaki P, Kotzakioulafi E, Chourdakis M. et al. Impact of Crocus sativus L. on metabolic profile in patients with diabetes mellitus or metabolic syndrome: A systematic review. Nutrients 2020; 12: 1424
• 14 Gudarzi S, Jafari M, Pirzad Jahromi G. et al. Evaluation of modulatory effects of saffron (Crocus sativus L.) aqueous extract on oxidative stress in ischemic stroke patients: a randomized clinical trial. Nutr Neurosci 2022; 25: 1137-1146
• 15 Guo ZL, Li MX, Li XL. et al. Crocetin: A systematic review. Front Pharmacol 2022; 12: 745683 DOI: 10.3389/fphar.2021.745683.
• 16 Heidari Z, Daei M, Khalili H, Sahebkar A. Bleeding complication in a patient with concomitant use of rivaroxaban and saffron supplement: a case report. Cardiovasc Hematol Disord Drug Targets 2022; Apr 18 DOI: 10.2174/1871529X22666220418102545.
• 17 Jomehpour H, Aghayan S, Khosravi A, Afzaljavan F. The effect of Krocina™ on decreasing substance user withdrawal syndrome, craving, depression and stress: A double-blind randomized parallel clinical trial. Subst Use Misuse 2022; 57: 613-620
• 18 Karimi E, Shahdadian F, Hadi A. et al. The effect of saffron (Crocus sativus L.) supplementation on renal function: A systematic review and meta-analysis of randomized controlled clinical trials. Int J Clin Pract 2022; 2022: 9622546
• 19 Karimi E, Farrokhzad A, Darand M, Arab A. The effect of saffron consumption on liver function: A systematic review and meta-analysis of randomized controlled clinical trials. Complement Med Res 2021; 28: 453-462
• 20 Khalatbari-Mohseni A, Banafshe HR, Mirhosseini N. et al. The effects of crocin on psychological parameters in patients under methadone maintenance treatment: a randomized clinical trial. Subst Abuse Treat Prev Policy 2019; 14: 9
• 21 Khoshandam A, Razavi BM, Hosseinzadeh H. Interaction of saffron and its constituents with Nrf2 signaling pathway: A review. Iran J Basic Med Sci 2022; 25: 789-798
• 22 Lian J, Zhong Y, Li H. et al. Effects of saffron supplementation on improving sleep quality: a meta-analysis of randomized controlled trials. Sleep Med 2022; 92: 24-33
• 23 Lu C, Ke L, Li J. et al. Saffron (Crocus sativus L.) and health outcomes: a meta-research review of meta-analyses and an evidence mapping study. Phytomedicine 2021; 91: 153699
• 24 Marx W, Lane M, Rocks T. Effect of saffron supplementation on symptoms of depression and anxiety: a systematic review and meta-analysis. Nutr Rev 2019; nuz023 DOI: 10.1093/nutrit/nuz023.
• 25 Matraszek-Gawron R, Chwil M, Terlecki K, Skoczylas MM. Current knowledge of the antidepressant activity of chemical compounds from Crocus sativus L. Pharmaceuticals (Basel) 2022; 16: 58
• 26 Mobasseri M, Ostadrahimi A, Tajaddini A. et al. Effects of saffron supplementation on glycemia and inflammation in patients with type 2 diabetes mellitus: A randomized double-blind, placebo-controlled clinical trial study. Diabetes Metab Syndr 2020; 14: 527-534
• 27 Munirah MP, Norhayati MN, Noraini M. Crocus sativus for insomnia: A systematic review and meta-analysis. Int J Environ Res Public Health 2022; 19: 11658
• 28 Musazadeh V, Zarezadeh M, Faghfouri AH. et al. Saffron, as an adjunct therapy, contributes to relieve depression symptoms: An umbrella meta-analysis. Pharmacol Res 2022; 175: 105963
• 29 Nemat Shahi M, Asadi A, Behnam Talab E, Nemat Shahi M. The impact of saffron on symptoms of withdrawal syndrome in patients undergoing maintenance treatment for opioid addiction in Sabzevar Parish in 2017. Adv Med 2017; 2017: 1079132
• 30 Salek R, Dehghani M, Mohajeri SA. et al. Amelioration of anxiety, depression, and chemotherapy related toxicity after crocin administration during chemotherapy of breast cancer: A double blind, randomized clinical trial. Phytother Res 2021; 35: 5143-5153
• 31 Sanaie S, Nikanfar S, Kalekhane ZY. et al. Saffron as a promising therapy for diabetes and Alzheimer’s disease: mechanistic insights. Metab Brain Dis 2023; 38: 137-162
• 32 Sani A, Tajik A, Seiiedi SS. et al. A review of the anti-diabetic potential of saffron. Nutr Metab Insights 2022; 15 11786388221095223
• 33 Sarris J, Ravindran A, Yatham LN. et al. Clinician guidelines for the treatment of psychiatric disorders with nutraceuticals and phytoceuticals: The World Federation of Societies of Biological Psychiatry (WFSBP) and Canadian Network for Mood and Anxiety Treatments (CANMAT) Taskforce. World J Biol Psychiatry 2022; 23: 424-455
• 34 Sepahi S, Ghorani-Azam A, Hossieni SM. et al. Pharmacological effects of saffron and its constituents in ocular disorders from in vitro studies to clinical trials: A systematic review. Curr Neuropharmacol 2021; 19: 392-401
• 35 Setayesh L, Ashtary-Larky D, Clark CCT. et al. The effect of saffron supplementation on blood pressure in adults: A systematic review and dose-response meta-analysis of randomized controlled trials. Nutrients 2021; 13: 2736
• 36 Shamabadi A, Hasanzadeh A, Akhondzadeh S. The neuropsychotropic effects of Crocus sativus L. (saffron): an overview of systematic reviews and meta-analyses investigating its clinical efficacy in psychiatric and neurological disorders. Avicenna J Phytomed 2022; 12: 475-488
• 37 Tahmasbi F, Araj-Khodaei M, Mahmoodpoor A, Sanaie S. Effects of saffron (Crocus sativus L.) on anthropometric and cardiometabolic indices in overweight and obese patients: A systematic review and meta-analysis of randomized controlled trials. Phytother Res 2022; 36: 3394-3414
• 38 Tajaddini A, Roshanravan N, Mobasseri M. et al. The effect of saffron (Crocus sativus L.) on glycemia, lipid profile, and antioxidant status in patients with type-2 diabetes mellitus: A randomized placebo-controlled trial. Phytother Res 2023; 37: 388-398 DOI: 10.1002/ptr.7600.
• 39 Talebi M, Talebi M, Samarghandian S. Association of Crocus sativus with cognitive dysfunctions and Alzheimer’s disease: A systematic review. Biointerface Res Appl Chem 2021; 11: 7468-7492 DOI: 10.33263/BRIAC111.74687492.
• 40 Yang W, Qiu X, Wu Q. et al. Active constituents of saffron (Crocus sativus L.) and their prospects in treating neurodegenerative diseases (Review). Exp Ther Med 2023; 25: 235
• 41 Ghasemnejad-Berenji M. Immunomodulatory and anti-inflammatory potential of crocin in COVID-19 treatment. J Food Biochem 2021; 45: e13718 DOI: 10.1111/jfbc.13718.